The Cannabist Company Holdings, Inc. engages in the production and sale of cannabis-based medicinal products. The company is headquartered in Chelmsford, Massachusetts and currently employs 1,681 full-time employees. The company went IPO on 2019-04-29. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The firm operates 77 facilities, including 61 dispensaries and 16 cultivation and manufacturing facilities, including those under development. The firm is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The firm offers products spanning flower, edibles, oils and tablets, and manufactures brands, including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.
¿Quién es el CEO de Cannabist Company Holdings Inc?
Mr. David Hart es el Chief Executive Officer de Cannabist Company Holdings Inc, se unió a la empresa desde 2018.
¿Qué tal es el rendimiento del precio de la acción THE CANNABIST COMPANY HOLDINGS ?
El precio actual de THE CANNABIST COMPANY HOLDINGS es de $0.029, ha aumentado un 16% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Cannabist Company Holdings Inc?
Cannabist Company Holdings Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Cannabist Company Holdings Inc?
La capitalización bursátil actual de Cannabist Company Holdings Inc es $36.9M
¿Es Cannabist Company Holdings Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Cannabist Company Holdings Inc, incluyendo 0 fuerte compra, 0 compra, 4 mantener, 4 venta, y 0 fuerte venta